Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

A Dundalk-area man is the first person in Canada to receive a new, publicly funded treatment that better targets prostate cancer cells and is shown to prolong life.

A team from the Institute of Cancer Research, London, found NXP800 slowed the growth of prostate cancer cells, including ...

The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is ...

Prostate cancer resistant to hormone therapy could soon have a new treatment option. The Institute of Cancer Research (ICR), ...

The drug is already approved to treat non ... and the ANZUP trial looking at adjuvant (post-surgery) use of Nubeqa in localised prostate cancer with a high risk of recurrence.

In today’s health-conscious world, prostate health has become an essential focus for men of all ages. As the population ages, issues related to prostate health have surged dramatically, sparking a ...

Drug treatment of BPH was initially viewed with suspicion by ... Before reaching a conclusion on the use of combination therapy for BPH, one other piece of evidence should be presented.

ProstaVive is an advanced formula that supports the healthy functioning of prostate glands, promoting overall well-being in ...

Anticancer Peptide Market Offers US$ 18 Billion Opportunity Says Kuick Research. Delhi, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The ...

As men age, prostate health issues can become prevalent. The prostate is a small gland and grows larger as you get older.